Company Filing History:
Years Active: 1998
Title: Garvin Bixler: Innovator in Synthetic Peptides
Introduction
Garvin Bixler is a notable inventor based in Fairport, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides. His work focuses on creating innovative solutions that enhance medical applications.
Latest Patents
Garvin Bixler holds a patent for "Synthetic peptides representing a T-cell epitope as a carrier molecule." This invention relates to novel T-cell epitopes derived from bacterial products. The epitopes can be utilized in the preparation of conjugates with medically useful antigens, haptens, or antigenic determinants. These conjugates are designed to elicit antibody responses similar to those produced by antigens covalently coupled to carrier proteins. In vaccine compositions, they provide a safer and more economical alternative for conjugate vaccines.
Career Highlights
Garvin Bixler is associated with Praxis Biologics, Inc., where he continues to advance his research and development efforts. His work has the potential to impact vaccine development and improve immunological responses in patients.
Collaborations
Throughout his career, Garvin has collaborated with esteemed colleagues, including Subramonia Pillai and Richard Insel. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Garvin Bixler is a distinguished inventor whose work in synthetic peptides is paving the way for advancements in medical science. His contributions are vital for the development of effective vaccines and therapeutic solutions.